Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
Dizdar
Omer
O
Yürekli
Banu Sarer
BS
Pürnak
Tugrul
T
Aksu
Salih
S
Haznedaroglu
Ibrahim Celalettin
IC
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008297:Male; D015275:Tumor Lysis Syndrome / Q000209:etiology*; D014740:Vidarabine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine